Chenyu Lin

21PUBLICATIONS
144CO-AUTHORS
Haematological tumoursPhysiotherapyCancer therapy (excl. chemotherapy and radiation therapy)Te urupare me te whai wāhi Māori ki te mātauranga (Māori responsiveness and engaged education)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 31, 2026
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

|Jun 25, 2026
Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL.

|May 19, 2026
Consensus recommendations for CAR T-cell administration in adult acute lymphoblastic leukemia: a modified Delphi study.

|May 16, 2026
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia.

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Jan 07, 2026
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.

Talha Badar, Ludovica Marando, Eric Latorre

Pageof 4

Frequent Collaborators

7 joint publications

Lori S Muffly

7 joint publications

Joshua Sasine

7 joint publications

Aaron C Logan

6 joint publications

Talal Hilal